NCT06465303 - A Study of RTP-026 to Assess Safety, Tolerability and Efficacy in Patients With ST-Elevation Myocardial Infarction (STEMI) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 16, 2024

Primary Completion Date

December 21, 2025

Study Completion Date

December 21, 2025

Conditions

ST Elevation Myocardial Infarction

Interventions

DRUG

RTP-026

Intervention is for each subject administered as three 30-minutes infusions of either A: 25μg/kg RTP-026; or B: ≥ 26μg/kg and ≤75μg/kg RTP-026; or C: A maximum of 3 x treatment dose RTP-026 as given in B;

DRUG

Placebo

Intervention is for each subject administered as three 30-minutes infusions of placebo

Trial Locations (1)

2100

RECRUITING

Hjertecenteret, Rigshospitalet, Copenhagen